These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17917525)

  • 1. PRO: Should aspirin be used in all women older than 65 years to prevent stroke?
    Hsia J
    Prev Cardiol; 2007; 10 Suppl 4():6-11. PubMed ID: 17917525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CON: Should aspirin be used in all women older than 65 years to prevent stroke?
    Buring JE
    Prev Cardiol; 2007; 10 Suppl 4():12-8. PubMed ID: 17917526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.
    Sanmuganathan PS; Ghahramani P; Jackson PR; Wallis EJ; Ramsay LE
    Heart; 2001 Mar; 85(3):265-71. PubMed ID: 11179262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does an aspirin a day really keep a stroke away?
    Mosca L
    Prev Cardiol; 2007; 10 Suppl 4():26-7. PubMed ID: 17917528
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
    Wolff T; Miller T; Ko S
    Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.
    Kunutsor SK; Seidu S; Khunti K
    Diabet Med; 2017 Mar; 34(3):316-327. PubMed ID: 27086572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials.
    Berger JS; Lala A; Krantz MJ; Baker GS; Hiatt WR
    Am Heart J; 2011 Jul; 162(1):115-24.e2. PubMed ID: 21742097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin in the treatment and prevention of cardiovascular disease.
    Gaziano JM; Skerrett PJ; Buring JE
    Haemostasis; 2000; 30 Suppl 3():1-13. PubMed ID: 11182624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.
    Matías-Guiu J; Ferro JM; Alvarez-Sabín J; Torres F; Jiménez MD; Lago A; Melo T;
    Stroke; 2003 Apr; 34(4):840-8. PubMed ID: 12649515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in primary prevention of cardiovascular disease in the elderly.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Montone RA; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):326-327. PubMed ID: 31504373
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
    van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B
    JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
    ; Baigent C; Blackwell L; Collins R; Emberson J; Godwin J; Peto R; Buring J; Hennekens C; Kearney P; Meade T; Patrono C; Roncaglioni MC; Zanchetti A
    Lancet; 2009 May; 373(9678):1849-60. PubMed ID: 19482214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectives.
    Bezerra DC; Bogousslavsky J
    Cerebrovasc Dis; 2005; 20 Suppl 2():109-18. PubMed ID: 16327260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Meta-Analysis of Aspirin for the Primary Prevention of Cardiovascular Diseases in the Context of Contemporary Preventive Strategies.
    Shah R; Khan B; Latham SB; Khan SA; Rao SV
    Am J Med; 2019 Nov; 132(11):1295-1304.e3. PubMed ID: 31153866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin use for primary prevention in elderly patients.
    Terrosu P
    Monaldi Arch Chest Dis; 2016 Jun; 84(1-2):728. PubMed ID: 27374042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin as preventive therapy in patients with asymptomatic vascular disease.
    Berger JS
    JAMA; 2010 Mar; 303(9):880-2. PubMed ID: 20197537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.